Tracheal Intubation for Pediatric ICU Safety

(NEAR4KIDs Trial)

Recruiting at 72 trial locations

Overseen By Hayley Buffman, MPH

Age: Any Age

Sex: Any

Trial Phase: Academic

Sponsor: Children's Hospital of Philadelphia

Disqualifiers: Operating suites

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

150000 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve the safety and quality of procedures used to help children breathe in intensive care units. Researchers are examining various methods for performing advanced airway interventions, such as inserting a breathing tube or using a laryngeal mask, particularly in emergency situations. Children who have undergone breathing interventions in a pediatric ICU or emergency department may be suitable candidates for this study. The goal is to make these critical procedures safer and more effective for children in these settings. As an unphased trial, participation offers an opportunity to contribute to pioneering research that could enhance pediatric care.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to improve the safety and quality of tracheal intubation in pediatric ICUs. Unlike traditional methods that focus primarily on the technical aspects of intubation, this trial is exploring comprehensive protocols that emphasize minimizing risks and enhancing patient outcomes. By potentially establishing new best practices, the trial could lead to more efficient, safer intubation procedures, reducing complications and improving the care experience for young patients.

Who Is on the Research Team?

Vinay Nadkarni, MD. MS

Principal Investigator

Children's Hospital of Philadelphia

Are You a Good Fit for This Trial?

Inclusion Criteria

Primary advanced airway events (on patients of all ages) in the PICU, CICU, NICU, DR and ED including: Tracheal Intubation, Laryngeal mask placement, Emergency tracheostomy and/or cricothyrotomy

Failed extubation attempts or unplanned extubations that require re-intubation will be considered a new primary intubation.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Data Collection

Baseline data is collected to describe current practice in pediatric ICUs, CICUs, NICUs, EDs, and DRs

4 weeks

Quality Improvement Intervention

Implementation of quality improvement interventions based on collected benchmarked data

Ongoing

Follow-up

Participants are monitored for safety and effectiveness after intervention

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Tracheal Intubation

Who Is Running the Clinical Trial?

Children's Hospital of Philadelphia

Lead Sponsor

Trials

749

Recruited

11,400,000+

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Trials

415

Recruited

6,777,000+